Alveolar Macrophages — Comprehensive Notes (15 Marks)

1. Introduction & Definition

2. Origin & Development

Embryonic Origin

• Yolk sac-derived macrophages populate the lung early in embryogenesis and are capable of self-renewal, persisting as long-lived tissue-resident cells.
• The fetal liver and postnatal bone marrow contribute to interstitial macrophages and, to a lesser extent, to alveolar macrophages during steady state and after injury.

Key point: Alveolar macrophages are primarily derived from the yolk sac, while interstitial macrophages are predominantly derived from the fetal liver and circulating monocytes — a distinction in origin that correlates with distinct transcriptional signatures and functions.

3. Morphology & Identification

• Large, mononuclear cells with an abundant, vacuolated cytoplasm
• Contain secondary lysosomes and phagosomes filled with ingested material
• Stain strongly for non-specific esterase (monocyte lineage marker)
• Surface markers: CD68+, CD11c+ (high), SiglecF+ (mouse), CD206+
• Distinct from interstitial macrophages by their transcriptional signature, location, and function
• In smokers and heavily polluted environments, they appear "dust-laden" or "soot-laden" (visible carbon/particle inclusions)

4. Location

• Reside in the alveolar lumen, lying on the alveolar epithelial surface (type I and type II pneumocytes)
• Exist within the mixed environment of epithelial lining fluid (surfactant, immunoglobulins, defensins) and inhaled air
• Also present in terminal bronchioles (as "bronchioloalveolar macrophages")
• The pool is maintained by a combination of local self-renewal and slow recruitment from blood monocytes

5. Primary Functions

A. Phagocytosis of Microbes and Particulates (most important function)

• AMs phagocytose a wide spectrum of inhaled microbes (bacteria, fungi, viruses) and inert particulates (dust, carbon, silica)
• Under basal conditions: particulates are enclosed in phagosomes → fuse with lysosomes → degraded by acid-pH hydrolytic enzymes
• Resistant organisms (e.g., Mycobacterium tuberculosis) and insoluble particles (e.g., crystalline silica) evade degradation and become sequestered in secondary lysosomes for the life span of the macrophage
• Particle-laden macrophages are cleared via the mucociliary escalator (crawl into airways) or undergo apoptosis and are cleared by neighbouring phagocytes
• Some macrophages remain in the lung for extended periods, die, and release their particle burden for re-phagocytosis

B. Clearance of Pulmonary Surfactant

• AMs actively contribute to normal surfactant homeostasis — they engulf and catabolise excess surfactant lipids and proteins
• This function is critically highlighted in Pulmonary Alveolar Proteinosis (PAP):
  • Characterised by accumulation of proteinaceous, lipid-rich surfactant in alveoli → impaired gas exchange
  • AM numbers are reduced, and those present are inefficient in surfactant clearance
  • PAP is associated with anti-GM-CSF autoantibodies, underscoring the importance of GM-CSF for AM function (GM-CSF drives AM differentiation via PU.1)
• Surfactant proteins SP-A and SP-D suppress AM phagocytosis via interaction with SIRP-α, modulating immune tone

C. Tonic Suppression of Inflammation and Adaptive Immunity (critical regulatory role)

• AMs play a critically important role in tonic suppression of alveolar inflammation and adaptive immunity
• The concept: the lung tolerates inhaled microbes/particulates until a threshold burden is reached
  • Below threshold → AMs phagocytose and degrade → no inflammatory response
  • Above threshold → microbes are taken up by resident dendritic cells (DCs) that "snorkel" through tight junctions of the alveolar epithelium
  • DCs then augment adaptive immune responses
• Experimental evidence: depletion of AMs with liposome-encapsulated clodronate → augments antigen presentation by pulmonary DCs → augments adaptive immune responses to intratracheal antigens
• This suppressive function prevents inappropriate inflammation to harmless inhaled antigens

6. Pattern Recognition Receptors (PRRs)

MARCO and SR-AI/II protect against inhaled oxidants by scavenging oxidised lipids — Murray & Nadel's, p. 338

7. Cytokine Production & Immunological Role

Pro-inflammatory (M1-like) activation — classical:

• Secrete: IL-1β, IL-6, IL-12, IL-18, TNF-α
• Enhanced ROS, NO production via iNOS
• Upregulate MHC class II → antigen presentation
• Anti-tumour, anti-microbial activity

Anti-inflammatory (M2-like) activation — alternative:

• Secrete: IL-10, TGF-β, arginase-1
• Promote tissue repair, fibrosis, immune regulation
• Maintain alveolar homeostasis under steady-state conditions

Under basal/steady-state conditions, AMs are predominantly in an anti-inflammatory, immunosuppressive phenotype — this is physiologically important to prevent autoimmunity and inappropriate responses to harmless inhaled antigens.

Key cytokines secreted:

• TGF-β, IL-10, PGE₂: Suppress T-cell activation and DC maturation
• MCP-1 (CCL2): Recruit monocytes during infection
• IL-8 (CXCL8): Recruit neutrophils
• IL-12, IL-23: Link innate to adaptive immunity

8. Role of GM-CSF in AM Function

• GM-CSF (granulocyte-macrophage colony-stimulating factor) is essential for AM development and function
• Acts via PU.1 transcription factor to regulate:
  • AM differentiation
  • FcγR-mediated phagocytosis
  • IL-18/IFN-γ axis (innate → adaptive immunity linkage)
• GM-CSF deficiency (or anti-GM-CSF antibodies) → failure of AM maturation → Pulmonary Alveolar Proteinosis
• Inhaled GM-CSF is used therapeutically in PAP

9. Transcriptional Signatures & Tissue Identity

• AMs have a unique transcriptional signature adapted to the lung environment
• All tissue-resident macrophages share core macrophage signature genes, but each displays organ-specific signatures
• Key AM-specific transcription factors: PU.1, C/EBPα, PPARγ (PPARγ is essential for AM identity — knockout mice develop PAP-like syndrome)
• Interstitial macrophages, by contrast, share a conserved transcriptional profile across multiple organs (lung, skin, heart, intestine), suggesting a common function in different tissues

10. AM vs. Interstitial Macrophage — Key Differences

11. Clinical Correlations (Exam High-Yield)

12. Summary Diagram of Functions

13. Quick Recall Points for Exam

1. Three primary functions: phagocytosis, surfactant clearance, immune suppression
2. Origin: yolk sac (embryonic), self-renewing pool
3. PAP = prototype disease of AM dysfunction (anti-GM-CSF Abs → PU.1 failure)
4. GM-CSF → PU.1 is the master axis for AM development
5. PPARγ is essential for AM identity
6. M. tuberculosis exploits the AM — evades lysosomal fusion
7. Silica → cannot be degraded → NLRP3 → IL-1β → fibrosis
8. Depletion of AMs → enhances DC-mediated adaptive immunity (loss of tonic suppression)
9. Surfactant proteins (SP-A, SP-D) modulate AM activity via SIRP-α
10. Interstitial macrophages ≠ alveolar macrophages (different origin, transcriptome, function)